![]() | Yahoo! Health - My Alerts - Edit Alert |
Tuesday, Feb 12, 2013 11:11 AM EST | |
Leading Patient Associations Join Top Pharma at Patient Centricity Summit, Toronto Tue, 12 Feb, 2013 07:42 AM PST RX&D, The Canadian Diabetes Association, Kidney Cancer Canada and the Canadian PKU & Allied Disorders are to host keynote speeches at the Patient Centricity Summit 2013 alongside top pharma CEOs. (PRWeb February 12, 2013) Read the full story at http://www.prweb.com/releases/2013/2/prweb10417683.htm UNMC Doctor Honored Tue, 12 Feb, 2013 07:10 AM PST A University of Nebraska Medical Center endocrinologist, Cyrus Desouza, M.D., has been named the first recipient of the Ervin and Dorothy Schulz Medical Professorship for Diabetes Research. Caloric restriction and exercise help prevent pregnancy complications in obese women Tue, 12 Feb, 2013 06:54 AM PST Washington, February 12 : Consistent physical activity and healthier lifestyle changes beginning in a woman's first trimester can prevent excessive weight gain in obese pregnant women, helping to avoid preterm delivery, hypertension and gestational diabetes, suggests a new study. Birth order linked to increased risk of diabetes, metabolic disorders Tue, 12 Feb, 2013 06:28 AM PST Long a source of sibling rivalry, birth order may raise the risk of first-born children developing diabetes or high blood pressure, according to a recent study. Food and drink companies are using the same dodgy tactics as tobacco companies to protect profits, leading experts warn Tue, 12 Feb, 2013 06:10 AM PST The tricks undermine public health policies designed to combat obesity, diabetes and alcohol-related illness, say researchers writing in The Lancet. EpiVax-Novozymes Tregitope-Albumin Fusion Moves 'Paradigm-Shifting' Treatment for Diabetes Closer to Clinical Trials prnewswire.com Tue, 12 Feb, 2013 06:00 AM PST PROVIDENCE, R.I., Feb. 12, 2013 /PRNewswire/ --Â EpiVax , Inc. is pleased to announce a new Collaborative Research Agreement with Novozymes Biopharma. The collaboration will enable EpiVax to rapidly advance ... | |
|
No comments:
Post a Comment